Summary

The global Medical Neural Interface Devices market is projected to grow from US$ 1185 million in 2025 to US$ 2017 million by 2032, at a CAGR of 7.9% (2026-2032), driven by critical product segments and diverse end‑use applications.
Medical neural interface devices comprise medical-grade technologies that directly record from, stimulate, or establish functional communication with neural tissue or neural activity. The market centers on standalone neural interface electrodes, leads and arrays, integrated implantable neural interface systems, and qualifying non-invasive medical brain-computer interface systems. Products span cortical surface, intracortical, deep intracerebral, spinal cord, peripheral nerve, endovascular and non-invasive central nervous system interfaces, with designs ranging from temporary diagnostic electrodes to chronic implanted sensing and stimulation interfaces. Key technical attributes include electrode geometry, contact density, implant duration, biocompatible materials, signal quality, directional stimulation, sensing, closed-loop control and long-term reliability. For therapeutic neuromodulation platforms, the measured economic object is the direct neural-contact lead or electrode portion rather than the broader pulse-generator and programmer ecosystem. Principal clinical uses include epilepsy localization and presurgical mapping, functional neurosurgery, therapeutic neuromodulation, neurorehabilitation, assistive control and neuroprosthetic restoration.
Key Findings
Global 2026 market volume reaches approximately 586.8 thousand units
Weighted global ASP is approximately US$2,183 per unit in 2026
Peripheral nerve interfaces represent about 42% of 2026 market value
Standalone electrodes and arrays account for roughly 97% in 2026
Non-invasive CNS interfaces are the fastest-growing approved neural-target segment
Market Trends
The market is moving from conventional recording-only or stimulation-only hardware toward sensing-enabled, closed-loop, adaptive and increasingly bidirectional neural interfaces. Mature therapeutic leads for spinal cord, deep brain, sacral and vagus nerve stimulation continue to provide the commercial base, while higher-channel-count electrodes, directional stimulation, flexible interfaces, integrated sensing and software-supported control are increasing product complexity and value density. Non-invasive medical BCI is progressing from research-oriented systems toward repeatable rehabilitation deployment, while implantable BCI entered an early commercial phase in 2026 but remains a very small part of current demand. The long-term direction is therefore an upgrade of the established neural-interface installed base rather than a wholesale replacement of mature neuromodulation by BCI.
Market Dynamics
Drivers
Procedure growth, broader clinical penetration and the expanding installed base of implanted therapies are the principal volume drivers. Replacement cycles provide recurring demand in mature neuromodulation, while sensing, adaptive stimulation and closed-loop functionality encourage product upgrades. Growth is also supported by increasing adoption of peripheral nerve stimulation, international diffusion of established therapies, and wider hospital use of neural interfaces in epilepsy, functional neurosurgery and rehabilitation.
Restraints
Invasive products face persistent constraints from surgical risk, long-term implant stability, biocompatibility, infection risk and the need to demonstrate durable clinical benefit. Commercial adoption also depends on reimbursement, physician training, hospital workflow integration and regulatory evidence. Qualified implantable-device manufacturing capacity is available, but switching materials, suppliers or production sites can require lengthy validation and regulatory work, limiting supply-chain flexibility.
Opportunities
The strongest incremental opportunities lie in peripheral nerve interfaces, sensing-enabled and closed-loop implants, non-invasive rehabilitation BCI and selective implantable BCI applications where functional benefit can be demonstrated clearly. Higher-density cortical interfaces, directional leads, flexible arrays and neural-data-enabled clinical software can increase value per procedure. Longer term, assistive communication, digital-device control and motor or sensory neuroprosthetic restoration could create additional demand beyond traditional therapeutic stimulation.
Challenges
The industry must improve chronic implant reliability while controlling surgical complexity and manufacturing cost. Connected and software-intensive interfaces introduce cybersecurity, software lifecycle and neural-data governance requirements in addition to conventional medical-device quality controls. Emerging BCI developers also face the risk that clinical enrollment, reimbursement and commercial patient adoption develop more slowly than engineering investment and manufacturing capacity.
Industry Chain Analysis
The upstream chain includes platinum, iridium and other noble-metal electrode materials, titanium, nitinol, medical polymers, specialty wire and tubing, microelectronics, ASICs, feedthroughs, coatings and hermetic packaging technologies. Value creation depends less on commodity availability than on implant-grade material specifications, qualified suppliers, microfabrication capability, cleanliness, biocompatibility and validated long-term reliability. Supplier qualification and manufacturing-site transfer can require extended verification, making approved sourcing and process know-how important barriers to entry. The midstream combines specialist electrode and lead manufacturers, implantable-device CDMOs, system integrators and branded medical-device platforms. Downstream commercialization typically runs through direct clinical sales teams, distributors and hospital procurement, supported by physician training and procedure support. Core customers include neurosurgical centers, comprehensive epilepsy centers, pain and neuromodulation clinics, rehabilitation hospitals and rehabilitation centers, while payment ultimately depends on hospital budgets, public or private insurance and procedure reimbursement. Specialized manufacturing, regulatory execution and clinical support therefore capture substantial value alongside the branded product itself.
Segment Insights
Standalone Neural Interface Electrodes and Arrays remain the dominant product architecture, representing about 96.6% of market value in 2026. The category is anchored by mature SCS, DBS, SNM, VNS, RNS and other therapeutic interface leads as well as SEEG, depth, cortical and intracortical electrodes. Integrated implantable neural interface systems remain at an early commercial stage, while non-invasive medical BCI systems already form a distinct commercial segment supported by rehabilitation-oriented deployments. By interface placement and neural target, Peripheral Nerve Interfaces are the largest segment at approximately 42.2% of 2026 market value, followed by Spinal Cord Interfaces at about 31.2% and Deep Intracerebral Interfaces at about 18.7%. Non-invasive CNS Interfaces start from a smaller base but are modeled as the fastest-growing approved neural-target segment, with a 2026–2032 CAGR of about 22.7%. Cortical surface and intracortical interfaces also gain share as higher-density recording, closed-loop applications and early BCI commercialization expand, while endovascular interfaces remain an investigational technology route without modeled commercial revenue.
Downstream Market Opportunities
The largest near- and medium-term opportunity remains therapeutic neuromodulation, where procedure penetration, replacement demand and expansion into peripheral nerve applications support recurring lead and electrode consumption. Epilepsy diagnosis, localization and presurgical mapping continue to sustain specialist intracranial electrode demand, while functional neurosurgery creates opportunities for increasingly precise recording and stimulation interfaces. Neurorehabilitation is becoming an important commercial pathway for non-invasive BCI because a reusable system can support repeated treatment across multiple patients in hospitals and rehabilitation centers. Assistive communication, digital control and motor or sensory restoration offer substantial longer-term potential but depend on stronger chronic clinical evidence and scalable reimbursement.
Regional Insights
North America remains the most mature commercial ecosystem for implanted neuromodulation, supported by established specialist centers, extensive installed bases, physician training networks and reimbursement pathways. Growth within mature U.S. categories is uneven, increasing the importance of product upgrades, peripheral nerve stimulation and replacement demand. Europe provides a broad clinical market for established stimulation and intracranial electrode technologies, although MDR compliance, notified-body requirements and device-registration obligations increase commercialization complexity. China and the wider Asian market are gaining strategic importance through domestic interface manufacturing, rehabilitation BCI deployment and translation of selected implantable BCI technologies into regulated clinical products. The regional structure is therefore evolving from predominantly mature Western adoption toward a more geographically diversified innovation and commercialization base.
Competitive Landscape Analysis
Competition is concentrated within individual therapeutic segments but fragmented across the overall medical neural interface market. Medtronic, Boston Scientific, Abbott and LivaNova occupy strong positions in mature implanted therapeutic interfaces through clinical evidence, physician relationships, installed bases and broad support infrastructures, while NeuroPace has a differentiated position in closed-loop epilepsy therapy. Specialist manufacturers such as DIXI Medical, Ad-Tech Medical Instrument, CorTec, Blackrock Neurotech and other intracranial-electrode companies compete through electrode design, clinical specialization and customization rather than platform breadth. Cirtec Medical, Integer and Valtronic form a separate strategic manufacturing layer by supplying implantable leads, components and system-development capabilities to OEM customers. In next-generation BCI, BroRay Technology has entered early regulated clinical commercialization, while Precision Neuroscience has crossed an important FDA regulatory milestone for its cortical electrode. Neuralink, Paradromics, Synchron, StairMed, Gbrain and neuroloop remain primarily clinical or pre-market competitors. The competitive direction is increasingly shaped by portfolio acquisitions, closed-loop sensing, specialized manufacturing, software integration and regulatory execution rather than price alone.
Report Scope
This definitive report equips business leaders, decision-makers, and stakeholders with a 360° view of the global Medical Neural Interface Devices market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2021–2025) and delivers forecasts through 2032, illuminating demand trends and growth drivers.
By segmenting the market by Product Architecture and by Clinical Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customer distribution pattern.
Granular regional insights cover five major markets (North America, Europe, APAC, South America, and MEA) with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers (sales volume, revenue, margins, pricing strategies, and major customers) and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
DIXI Medical
Ad-Tech Medical Instrument
Sinovation Medical
PMT Corporation
Rishena Medical
CorTec
Spes Medica
Blackrock Neurotech
Alpha Omega
Sensomedical
Unique Medical
inomed
ALCIS
FHC
LivaNova
Precision Neuroscience
NeuroPace
WISE
SceneRay Medical
PINS Medical
BroRay Technology
Medtronic
Abbott
Boston Scientific
Cirtec Medical
Integer
Valtronic
LIFESCAPES
g.tec medical engineering
Neurostyle
ZhenTec
RxHeal Medical
Xiangyu Medical
Neurobots
LANG
MEF
StairMed
Neuralink
Paradromics
Synchron
Gbrain
neuroloop
Segment by Product Architecture
Standalone Neural Interface Electrodes and Arrays
Integrated Implantable Neural Interface Systems
Non-invasive Medical Brain-Computer Interface Systems
Segment by Interface Placement and Neural Target
Cortical Surface Interfaces
Intracortical Interfaces
Deep Intracerebral Interfaces
Spinal Cord Interfaces
Peripheral Nerve Interfaces
Endovascular Neural Interfaces
Non-invasive CNS Interfaces
Segment by Clinical Application
Epilepsy Diagnosis, Localization and Presurgical Mapping
Intraoperative Neural Mapping and Neuromonitoring
Functional Neurosurgery and Therapeutic Neuromodulation Support
Neurorehabilitation and Motor Recovery
Assistive Communication and Digital Device Control
Motor and Sensory Neuroprosthetic Restoration
Sales by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
China Taiwan
Southeast Asia (Indonesia, Vietnam, Thailand)
Europe
Germany
France
U.K.
Italy
Russia
Central and South America
Brazil
Argentina
Rest of Central and South America
Middle East, Africa
Turkey
Egypt
GCC Countries
South Africa
Chapter Outline
Chapter 1: Defines the Medical Neural Interface Devices study scope, segments the market by Product Architecture and by Clinical Application, etc, highlights segment size and growth potential
Chapter 2: Offers current market state, projects global revenue and sales to 2032, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape: ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves
Chapter 4: Unlocks high margin product segments: compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities: evaluates sales, revenue, and pricing by Clinical Application, identifies emerging use cases, and profiles leading customers by region and by Clinical Application
Chapter 6: North America: breaks down sales and revenue by Clinical Application and country, profiles key manufacturers and assesses growth drivers and barriers
Chapter 7: Europe: analyses regional sales, revenue and market by Clinical Application and manufacturers, flagging drivers and barriers
Chapter 8: Asia Pacific: quantifies sales and revenue by Clinical Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas
Chapter 9: Central & South America: measures sales and revenue by Clinical Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges
Chapter 10: Middle East and Africa: evaluates sales and revenue by Clinical Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth: details product specs, sales, revenue, margins; top manufactures 2025 sales breakdowns by product type, by Clinical Application, by sales region SWOT analysis, and recent strategic developments
Chapter 12: Supply chain: analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles
Chapter 13: Market dynamics: explores drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Allocate capital strategically to high growth regions (Chapters 6-10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

ページTOPに戻る

Table of Contents

1 Study Coverage
1.1 Introduction to Medical Neural Interface Devices: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Product Architecture
1.2.1 Global Medical Neural Interface Devices Market Size by Product Architecture, 2021 vs 2025 vs 2032
1.2.2 Standalone Neural Interface Electrodes and Arrays
1.2.3 Integrated Implantable Neural Interface Systems
1.2.4 Non-invasive Medical Brain-Computer Interface Systems
1.3 Market Segmentation by Interface Placement and Neural Target
1.3.1 Global Medical Neural Interface Devices Market Size by Interface Placement and Neural Target, 2021 vs 2025 vs 2032
1.3.2 Cortical Surface Interfaces
1.3.3 Intracortical Interfaces
1.3.4 Deep Intracerebral Interfaces
1.3.5 Spinal Cord Interfaces
1.3.6 Peripheral Nerve Interfaces
1.3.7 Endovascular Neural Interfaces
1.3.8 Non-invasive CNS Interfaces
1.4 Market Segmentation by Clinical Application
1.4.1 Global Medical Neural Interface Devices Market Size by Clinical Application, 2021 vs 2025 vs 2032
1.4.2 Epilepsy Diagnosis, Localization and Presurgical Mapping
1.4.3 Intraoperative Neural Mapping and Neuromonitoring
1.4.4 Functional Neurosurgery and Therapeutic Neuromodulation Support
1.4.5 Neurorehabilitation and Motor Recovery
1.4.6 Assistive Communication and Digital Device Control
1.4.7 Motor and Sensory Neuroprosthetic Restoration
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Medical Neural Interface Devices Revenue Estimates and Forecasts (2021-2032)
2.2 Global Medical Neural Interface Devices Revenue by Region
2.2.1 Revenue Comparison: 2021 vs 2025 vs 2032
2.2.2 Historical and Forecasted Revenue by Region (2021-2032)
2.2.3 Global Revenue-Based Market Share by Region (2021-2032)
2.3 Global Medical Neural Interface Devices Sales Estimates and Forecasts (2021-2032)
2.4 Global Medical Neural Interface Devices Sales by Region
2.4.1 Sales Comparison: 2021 vs 2025 vs 2032
2.4.2 Historical and Forecasted Sales by Region (2021-2032)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2021-2032)

3 Competitive Landscape
3.1 Global Medical Neural Interface Devices Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2021-2026)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2025)
3.2 Global Medical Neural Interface Devices Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2021-2026)
3.2.2 Global Key Manufacturer Revenue Ranking (2024 vs. 2025)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2021 vs 2025)
3.3.2 Manufacturer-Level Price Trends (2021-2026)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Key Manufacturers Market Share by Product Type
3.5.1 Standalone Neural Interface Electrodes and Arrays: Market Share by Key Manufacturers
3.5.2 Integrated Implantable Neural Interface Systems: Market Share by Key Manufacturers
3.5.3 Non-invasive Medical Brain-Computer Interface Systems: Market Share by Key Manufacturers
3.6 Global Medical Neural Interface Devices Market Concentration and Dynamics
3.6.1 Global Market Concentration
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

4 Product Segmentation
4.1 Global Medical Neural Interface Devices Sales Performance by Product Architecture
4.1.1 Global Medical Neural Interface Devices Sales Volume by Product Architecture (2021-2032)
4.1.2 Global Medical Neural Interface Devices Revenue by Product Architecture (2021-2032)
4.1.3 Global Average Selling Price (ASP) Trends by Product Architecture (2021-2032)
4.2 Global Medical Neural Interface Devices Sales Performance by Interface Placement and Neural Target
4.2.1 Global Medical Neural Interface Devices Sales Volume by Interface Placement and Neural Target (2021-2032)
4.2.2 Global Medical Neural Interface Devices Revenue by Interface Placement and Neural Target (2021-2032)
4.2.3 Global Average Selling Price (ASP) Trends by Interface Placement and Neural Target (2021-2032)
4.3 Product Technology Differentiation
4.4 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.4.1 High-Growth Niches and Adoption Drivers
4.4.2 Profitability Hotspots and Cost Drivers
4.4.3 Substitution Threats

5 Downstream Applications and Customers
5.1 Global Medical Neural Interface Devices Sales by Clinical Application
5.1.1 Global Historical and Forecasted Sales by Clinical Application (2021-2032)
5.1.2 Global Sales Market Share by Clinical Application (2021-2032)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Medical Neural Interface Devices Revenue by Clinical Application
5.2.1 Global Historical and Forecasted Revenue by Clinical Application (2021-2032)
5.2.2 Revenue-Based Market Share by Clinical Application (2021-2032)
5.3 Global Pricing Dynamics by Clinical Application (2021-2032)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Clinical Application

6 North America
6.1 North America Sales Volume and Revenue (2021-2032)
6.2 North America Key Manufacturers Sales Revenue in 2025
6.3 North America Medical Neural Interface Devices Sales and Revenue by Clinical Application (2021-2032)
6.4 North America Growth Accelerators and Market Barriers
6.5 North America Medical Neural Interface Devices Market Size by Country
6.5.1 North America Revenue by Country
6.5.2 North America Sales Trends by Country
6.5.3 US
6.5.4 Canada
6.5.5 Mexico

7 Europe
7.1 Europe Sales Volume and Revenue (2021-2032)
7.2 Europe Key Manufacturers Sales Revenue in 2025
7.3 Europe Medical Neural Interface Devices Sales and Revenue by Clinical Application (2021-2032)
7.4 Europe Growth Accelerators and Market Barriers
7.5 Europe Medical Neural Interface Devices Market Size by Country
7.5.1 Europe Revenue by Country
7.5.2 Europe Sales Trends by Country
7.5.3 Germany
7.5.4 France
7.5.5 U.K.
7.5.6 Italy
7.5.7 Russia

8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2021-2032)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2025
8.3 Asia-Pacific Medical Neural Interface Devices Sales and Revenue by Clinical Application (2021-2032)
8.4 Asia-Pacific Medical Neural Interface Devices Market Size by Region
8.4.1 Asia-Pacific Revenue by Region
8.4.2 Asia-Pacific Sales Trends by Region
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Southeast Asia
8.6.1 Southeast Asia Revenue by Country (2021 vs 2025 vs 2032)
8.6.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.7 China
8.8 Japan
8.9 South Korea
8.10 China Taiwan
8.11 India

9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2021-2032)
9.2 Central and South America Key Manufacturers Sales Revenue in 2025
9.3 Central and South America Medical Neural Interface Devices Sales and Revenue by Clinical Application (2021-2032)
9.4 Central and South America Investment Opportunities and Key Challenges
9.5 Central and South America Medical Neural Interface Devices Market Size by Country
9.5.1 Central and South America Revenue Trends by Country (2021 vs 2025 vs 2032)
9.5.2 Brazil
9.5.3 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2021-2032)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2025
10.3 Middle East and Africa Medical Neural Interface Devices Sales and Revenue by Clinical Application (2021-2032)
10.4 Middle East and Africa Investment Opportunities and Key Challenges
10.5 Middle East and Africa Medical Neural Interface Devices Market Size by Country
10.5.1 Middle East and Africa Revenue Trends by Country (2021 vs 2025 vs 2032)
10.5.2 GCC Countries
10.5.3 Turkey
10.5.4 Egypt
10.5.5 South Africa

11 Corporate Profile
11.1 DIXI Medical
11.1.1 DIXI Medical Corporation Information
11.1.2 DIXI Medical Business Overview
11.1.3 DIXI Medical Medical Neural Interface Devices Product Models, Descriptions and Specifications
11.1.4 DIXI Medical Medical Neural Interface Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.1.5 DIXI Medical Medical Neural Interface Devices Sales by Product in 2025
11.1.6 DIXI Medical Medical Neural Interface Devices Sales by Clinical Application in 2025
11.1.7 DIXI Medical Medical Neural Interface Devices Sales by Geographic Area in 2025
11.1.8 DIXI Medical Medical Neural Interface Devices SWOT Analysis
11.1.9 DIXI Medical Recent Developments
11.2 Ad-Tech Medical Instrument
11.2.1 Ad-Tech Medical Instrument Corporation Information
11.2.2 Ad-Tech Medical Instrument Business Overview
11.2.3 Ad-Tech Medical Instrument Medical Neural Interface Devices Product Models, Descriptions and Specifications
11.2.4 Ad-Tech Medical Instrument Medical Neural Interface Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.2.5 Ad-Tech Medical Instrument Medical Neural Interface Devices Sales by Product in 2025
11.2.6 Ad-Tech Medical Instrument Medical Neural Interface Devices Sales by Clinical Application in 2025
11.2.7 Ad-Tech Medical Instrument Medical Neural Interface Devices Sales by Geographic Area in 2025
11.2.8 Ad-Tech Medical Instrument Medical Neural Interface Devices SWOT Analysis
11.2.9 Ad-Tech Medical Instrument Recent Developments
11.3 Sinovation Medical
11.3.1 Sinovation Medical Corporation Information
11.3.2 Sinovation Medical Business Overview
11.3.3 Sinovation Medical Medical Neural Interface Devices Product Models, Descriptions and Specifications
11.3.4 Sinovation Medical Medical Neural Interface Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.3.5 Sinovation Medical Medical Neural Interface Devices Sales by Product in 2025
11.3.6 Sinovation Medical Medical Neural Interface Devices Sales by Clinical Application in 2025
11.3.7 Sinovation Medical Medical Neural Interface Devices Sales by Geographic Area in 2025
11.3.8 Sinovation Medical Medical Neural Interface Devices SWOT Analysis
11.3.9 Sinovation Medical Recent Developments
11.4 PMT Corporation
11.4.1 PMT Corporation Corporation Information
11.4.2 PMT Corporation Business Overview
11.4.3 PMT Corporation Medical Neural Interface Devices Product Models, Descriptions and Specifications
11.4.4 PMT Corporation Medical Neural Interface Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.4.5 PMT Corporation Medical Neural Interface Devices Sales by Product in 2025
11.4.6 PMT Corporation Medical Neural Interface Devices Sales by Clinical Application in 2025
11.4.7 PMT Corporation Medical Neural Interface Devices Sales by Geographic Area in 2025
11.4.8 PMT Corporation Medical Neural Interface Devices SWOT Analysis
11.4.9 PMT Corporation Recent Developments
11.5 Rishena Medical
11.5.1 Rishena Medical Corporation Information
11.5.2 Rishena Medical Business Overview
11.5.3 Rishena Medical Medical Neural Interface Devices Product Models, Descriptions and Specifications
11.5.4 Rishena Medical Medical Neural Interface Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.5.5 Rishena Medical Medical Neural Interface Devices Sales by Product in 2025
11.5.6 Rishena Medical Medical Neural Interface Devices Sales by Clinical Application in 2025
11.5.7 Rishena Medical Medical Neural Interface Devices Sales by Geographic Area in 2025
11.5.8 Rishena Medical Medical Neural Interface Devices SWOT Analysis
11.5.9 Rishena Medical Recent Developments
11.6 CorTec
11.6.1 CorTec Corporation Information
11.6.2 CorTec Business Overview
11.6.3 CorTec Medical Neural Interface Devices Product Models, Descriptions and Specifications
11.6.4 CorTec Medical Neural Interface Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.6.5 CorTec Recent Developments
11.7 Spes Medica
11.7.1 Spes Medica Corporation Information
11.7.2 Spes Medica Business Overview
11.7.3 Spes Medica Medical Neural Interface Devices Product Models, Descriptions and Specifications
11.7.4 Spes Medica Medical Neural Interface Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.7.5 Spes Medica Recent Developments
11.8 Blackrock Neurotech
11.8.1 Blackrock Neurotech Corporation Information
11.8.2 Blackrock Neurotech Business Overview
11.8.3 Blackrock Neurotech Medical Neural Interface Devices Product Models, Descriptions and Specifications
11.8.4 Blackrock Neurotech Medical Neural Interface Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.8.5 Blackrock Neurotech Recent Developments
11.9 Alpha Omega
11.9.1 Alpha Omega Corporation Information
11.9.2 Alpha Omega Business Overview
11.9.3 Alpha Omega Medical Neural Interface Devices Product Models, Descriptions and Specifications
11.9.4 Alpha Omega Medical Neural Interface Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.9.5 Alpha Omega Recent Developments
11.10 Sensomedical
11.10.1 Sensomedical Corporation Information
11.10.2 Sensomedical Business Overview
11.10.3 Sensomedical Medical Neural Interface Devices Product Models, Descriptions and Specifications
11.10.4 Sensomedical Medical Neural Interface Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.10.5 Sensomedical Recent Developments
11.11 Unique Medical
11.11.1 Unique Medical Corporation Information
11.11.2 Unique Medical Business Overview
11.11.3 Unique Medical Medical Neural Interface Devices Product Models, Descriptions and Specifications
11.11.4 Unique Medical Medical Neural Interface Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.11.5 Unique Medical Recent Developments
11.12 inomed
11.12.1 inomed Corporation Information
11.12.2 inomed Business Overview
11.12.3 inomed Medical Neural Interface Devices Product Models, Descriptions and Specifications
11.12.4 inomed Medical Neural Interface Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.12.5 inomed Recent Developments
11.13 ALCIS
11.13.1 ALCIS Corporation Information
11.13.2 ALCIS Business Overview
11.13.3 ALCIS Medical Neural Interface Devices Product Models, Descriptions and Specifications
11.13.4 ALCIS Medical Neural Interface Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.13.5 ALCIS Recent Developments
11.14 FHC
11.14.1 FHC Corporation Information
11.14.2 FHC Business Overview
11.14.3 FHC Medical Neural Interface Devices Product Models, Descriptions and Specifications
11.14.4 FHC Medical Neural Interface Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.14.5 FHC Recent Developments
11.15 LivaNova
11.15.1 LivaNova Corporation Information
11.15.2 LivaNova Business Overview
11.15.3 LivaNova Medical Neural Interface Devices Product Models, Descriptions and Specifications
11.15.4 LivaNova Medical Neural Interface Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.15.5 LivaNova Recent Developments
11.16 Precision Neuroscience
11.16.1 Precision Neuroscience Corporation Information
11.16.2 Precision Neuroscience Business Overview
11.16.3 Precision Neuroscience Medical Neural Interface Devices Product Models, Descriptions and Specifications
11.16.4 Precision Neuroscience Medical Neural Interface Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.16.5 Precision Neuroscience Recent Developments
11.17 NeuroPace
11.17.1 NeuroPace Corporation Information
11.17.2 NeuroPace Business Overview
11.17.3 NeuroPace Medical Neural Interface Devices Product Models, Descriptions and Specifications
11.17.4 NeuroPace Medical Neural Interface Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.17.5 NeuroPace Recent Developments
11.18 WISE
11.18.1 WISE Corporation Information
11.18.2 WISE Business Overview
11.18.3 WISE Medical Neural Interface Devices Product Models, Descriptions and Specifications
11.18.4 WISE Medical Neural Interface Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.18.5 WISE Recent Developments
11.19 SceneRay Medical
11.19.1 SceneRay Medical Corporation Information
11.19.2 SceneRay Medical Business Overview
11.19.3 SceneRay Medical Medical Neural Interface Devices Product Models, Descriptions and Specifications
11.19.4 SceneRay Medical Medical Neural Interface Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.19.5 SceneRay Medical Recent Developments
11.20 PINS Medical
11.20.1 PINS Medical Corporation Information
11.20.2 PINS Medical Business Overview
11.20.3 PINS Medical Medical Neural Interface Devices Product Models, Descriptions and Specifications
11.20.4 PINS Medical Medical Neural Interface Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.20.5 PINS Medical Recent Developments
11.21 BroRay Technology
11.21.1 BroRay Technology Corporation Information
11.21.2 BroRay Technology Business Overview
11.21.3 BroRay Technology Medical Neural Interface Devices Product Models, Descriptions and Specifications
11.21.4 BroRay Technology Medical Neural Interface Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.21.5 BroRay Technology Recent Developments
11.22 Medtronic
11.22.1 Medtronic Corporation Information
11.22.2 Medtronic Business Overview
11.22.3 Medtronic Medical Neural Interface Devices Product Models, Descriptions and Specifications
11.22.4 Medtronic Medical Neural Interface Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.22.5 Medtronic Recent Developments
11.23 Abbott
11.23.1 Abbott Corporation Information
11.23.2 Abbott Business Overview
11.23.3 Abbott Medical Neural Interface Devices Product Models, Descriptions and Specifications
11.23.4 Abbott Medical Neural Interface Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.23.5 Abbott Recent Developments
11.24 Boston Scientific
11.24.1 Boston Scientific Corporation Information
11.24.2 Boston Scientific Business Overview
11.24.3 Boston Scientific Medical Neural Interface Devices Product Models, Descriptions and Specifications
11.24.4 Boston Scientific Medical Neural Interface Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.24.5 Boston Scientific Recent Developments
11.25 Cirtec Medical
11.25.1 Cirtec Medical Corporation Information
11.25.2 Cirtec Medical Business Overview
11.25.3 Cirtec Medical Medical Neural Interface Devices Product Models, Descriptions and Specifications
11.25.4 Cirtec Medical Medical Neural Interface Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.25.5 Cirtec Medical Recent Developments
11.26 Integer
11.26.1 Integer Corporation Information
11.26.2 Integer Business Overview
11.26.3 Integer Medical Neural Interface Devices Product Models, Descriptions and Specifications
11.26.4 Integer Medical Neural Interface Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.26.5 Integer Recent Developments
11.27 Valtronic
11.27.1 Valtronic Corporation Information
11.27.2 Valtronic Business Overview
11.27.3 Valtronic Medical Neural Interface Devices Product Models, Descriptions and Specifications
11.27.4 Valtronic Medical Neural Interface Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.27.5 Valtronic Recent Developments
11.28 LIFESCAPES
11.28.1 LIFESCAPES Corporation Information
11.28.2 LIFESCAPES Business Overview
11.28.3 LIFESCAPES Medical Neural Interface Devices Product Models, Descriptions and Specifications
11.28.4 LIFESCAPES Medical Neural Interface Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.28.5 LIFESCAPES Recent Developments
11.29 g.tec medical engineering
11.29.1 g.tec medical engineering Corporation Information
11.29.2 g.tec medical engineering Business Overview
11.29.3 g.tec medical engineering Medical Neural Interface Devices Product Models, Descriptions and Specifications
11.29.4 g.tec medical engineering Medical Neural Interface Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.29.5 g.tec medical engineering Recent Developments
11.30 Neurostyle
11.30.1 Neurostyle Corporation Information
11.30.2 Neurostyle Business Overview
11.30.3 Neurostyle Medical Neural Interface Devices Product Models, Descriptions and Specifications
11.30.4 Neurostyle Medical Neural Interface Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.30.5 Neurostyle Recent Developments
11.31 ZhenTec
11.31.1 ZhenTec Corporation Information
11.31.2 ZhenTec Business Overview
11.31.3 ZhenTec Medical Neural Interface Devices Product Models, Descriptions and Specifications
11.31.4 ZhenTec Medical Neural Interface Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.31.5 ZhenTec Recent Developments
11.32 RxHeal Medical
11.32.1 RxHeal Medical Corporation Information
11.32.2 RxHeal Medical Business Overview
11.32.3 RxHeal Medical Medical Neural Interface Devices Product Models, Descriptions and Specifications
11.32.4 RxHeal Medical Medical Neural Interface Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.32.5 RxHeal Medical Recent Developments
11.33 Xiangyu Medical
11.33.1 Xiangyu Medical Corporation Information
11.33.2 Xiangyu Medical Business Overview
11.33.3 Xiangyu Medical Medical Neural Interface Devices Product Models, Descriptions and Specifications
11.33.4 Xiangyu Medical Medical Neural Interface Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.33.5 Xiangyu Medical Recent Developments
11.34 Neurobots
11.34.1 Neurobots Corporation Information
11.34.2 Neurobots Business Overview
11.34.3 Neurobots Medical Neural Interface Devices Product Models, Descriptions and Specifications
11.34.4 Neurobots Medical Neural Interface Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.34.5 Neurobots Recent Developments
11.35 LANG
11.35.1 LANG Corporation Information
11.35.2 LANG Business Overview
11.35.3 LANG Medical Neural Interface Devices Product Models, Descriptions and Specifications
11.35.4 LANG Medical Neural Interface Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.35.5 LANG Recent Developments
11.36 MEF
11.36.1 MEF Corporation Information
11.36.2 MEF Business Overview
11.36.3 MEF Medical Neural Interface Devices Product Models, Descriptions and Specifications
11.36.4 MEF Medical Neural Interface Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.36.5 MEF Recent Developments
11.37 StairMed
11.37.1 StairMed Corporation Information
11.37.2 StairMed Business Overview
11.37.3 StairMed Medical Neural Interface Devices Product Models, Descriptions and Specifications
11.37.4 StairMed Medical Neural Interface Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.37.5 StairMed Recent Developments
11.38 Neuralink
11.38.1 Neuralink Corporation Information
11.38.2 Neuralink Business Overview
11.38.3 Neuralink Medical Neural Interface Devices Product Models, Descriptions and Specifications
11.38.4 Neuralink Medical Neural Interface Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.38.5 Neuralink Recent Developments
11.39 Paradromics
11.39.1 Paradromics Corporation Information
11.39.2 Paradromics Business Overview
11.39.3 Paradromics Medical Neural Interface Devices Product Models, Descriptions and Specifications
11.39.4 Paradromics Medical Neural Interface Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.39.5 Paradromics Recent Developments
11.40 Synchron
11.40.1 Synchron Corporation Information
11.40.2 Synchron Business Overview
11.40.3 Synchron Medical Neural Interface Devices Product Models, Descriptions and Specifications
11.40.4 Synchron Medical Neural Interface Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.40.5 Synchron Recent Developments

12 Value Chain and Supply-Chain Analysis
12.1 Medical Neural Interface Devices Industry Chain
12.2 Medical Neural Interface Devices Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Medical Neural Interface Devices Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2021-2032)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Medical Neural Interface Devices Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors

13 Medical Neural Interface Devices Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
13.4 Impact of U.S. Tariffs

14 Key Findings in the Global Medical Neural Interface Devices Study

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Global Medical Neural Interface Devices Market Size Growth Rate by Product Architecture, 2021 vs 2025 vs 2032 (US$ Million)
Table 2. Global Medical Neural Interface Devices Market Size Growth Rate by Interface Placement and Neural Target, 2021 vs 2025 vs 2032 (US$ Million)
Table 3. Global Medical Neural Interface Devices Market Size Growth Rate by Clinical Application, 2021 vs 2025 vs 2032 (US$ Million)
Table 4. Global Medical Neural Interface Devices Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 5. Global Medical Neural Interface Devices Revenue by Region (US$ Million), 2021-2026
Table 6. Global Medical Neural Interface Devices Revenue by Region (US$ Million), 2027-2032
Table 7. Global Medical Neural Interface Devices Sales Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (Units)
Table 8. Global Medical Neural Interface Devices Sales by Region (Units), 2021-2026
Table 9. Global Medical Neural Interface Devices Sales by Region (Units), 2027-2032
Table 10. Emerging Market Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 11. Global Medical Neural Interface Devices Sales by Manufacturers (Units), 2021-2026
Table 12. Global Medical Neural Interface Devices Sales Share by Manufacturers (2021-2026)
Table 13. Global Medical Neural Interface Devices Revenue by Manufacturers (US$ Million), 2021-2026
Table 14. Global Medical Neural Interface Devices Revenue-Based Market Share by Manufacturers (2021-2026)
Table 15. Global Key Manufacturers’Ranking Shift (2024 vs. 2025) (Based on Revenue)
Table 16. Global Manufacturer by Tier (Tier 1, Tier 2, and Tier 3), based on Medical Neural Interface Devices Revenue, 2025
Table 17. Global Medical Neural Interface Devices Average Gross Margin (%) by Manufacturer (2021 vs 2025)
Table 18. Global Medical Neural Interface Devices Average Selling Price (ASP) by Manufacturers (US$/Unit), 2021-2026
Table 19. Key Manufacturers Medical Neural Interface Devices Manufacturing Base and Headquarters
Table 20. Global Medical Neural Interface Devices Market Concentration Ratio (CR5)
Table 21. Key Market Entrant/Exit (2021-2025) – Drivers & Impact Analysis
Table 22. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 23. Global Medical Neural Interface Devices Sales Volume by Product Architecture (Units), 2021-2026
Table 24. Global Medical Neural Interface Devices Sales Volume by Product Architecture (Units), 2027-2032
Table 25. Global Medical Neural Interface Devices Revenue by Product Architecture (US$ Million), 2021-2026
Table 26. Global Medical Neural Interface Devices Revenue by Product Architecture (US$ Million), 2027-2032
Table 27. Global Medical Neural Interface Devices Sales Volume by Interface Placement and Neural Target (Units), 2021-2026
Table 28. Global Medical Neural Interface Devices Sales Volume by Interface Placement and Neural Target (Units), 2027-2032
Table 29. Global Medical Neural Interface Devices Revenue by Interface Placement and Neural Target (US$ Million), 2021-2026
Table 30. Global Medical Neural Interface Devices Revenue by Interface Placement and Neural Target (US$ Million), 2027-2032
Table 31. Technical Specifications by Key Product Type
Table 32. Global Medical Neural Interface Devices Sales by Clinical Application (Units), 2021-2026
Table 33. Global Medical Neural Interface Devices Sales by Clinical Application (Units), 2027-2032
Table 34. Medical Neural Interface Devices High-Growth Sectors Demand CAGR (2026-2032)
Table 35. Global Medical Neural Interface Devices Revenue by Clinical Application (US$ Million), 2021-2026
Table 36. Global Medical Neural Interface Devices Revenue by Clinical Application (US$ Million), 2027-2032
Table 37. Top Customers by Region
Table 38. Top Customers by Clinical Application
Table 39. North America Medical Neural Interface Devices Growth Accelerators and Market Barriers
Table 40. North America Medical Neural Interface Devices Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 41. North America Medical Neural Interface Devices Sales (Units) by Country (2021 vs 2025 vs 2032)
Table 42. Europe Medical Neural Interface Devices Growth Accelerators and Market Barriers
Table 43. Europe Medical Neural Interface Devices Revenue Grow Rate (CAGR) by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 44. Europe Medical Neural Interface Devices Sales (Units) by Country (2021 vs 2025 vs 2032)
Table 45. Asia-Pacific Medical Neural Interface Devices Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Asia-Pacific Medical Neural Interface Devices Sales (Units) by Country (2021 vs 2025 vs 2032)
Table 47. Asia-Pacific Medical Neural Interface Devices Growth Accelerators and Market Barriers
Table 48. Southeast Asia Medical Neural Interface Devices Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 49. Central and South America Medical Neural Interface Devices Investment Opportunities and Key Challenges
Table 50. Central and South America Medical Neural Interface Devices Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 51. Middle East and Africa Medical Neural Interface Devices Investment Opportunities and Key Challenges
Table 52. Middle East and Africa Medical Neural Interface Devices Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 53. DIXI Medical Corporation Information
Table 54. DIXI Medical Description and Major Businesses
Table 55. DIXI Medical Product Models, Descriptions and Specifications
Table 56. DIXI Medical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 57. DIXI Medical Sales Value Proportion by Product in 2025
Table 58. DIXI Medical Sales Value Proportion by Clinical Application in 2025
Table 59. DIXI Medical Sales Value Proportion by Geographic Area in 2025
Table 60. DIXI Medical Medical Neural Interface Devices SWOT Analysis
Table 61. DIXI Medical Recent Developments
Table 62. Ad-Tech Medical Instrument Corporation Information
Table 63. Ad-Tech Medical Instrument Description and Major Businesses
Table 64. Ad-Tech Medical Instrument Product Models, Descriptions and Specifications
Table 65. Ad-Tech Medical Instrument Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 66. Ad-Tech Medical Instrument Sales Value Proportion by Product in 2025
Table 67. Ad-Tech Medical Instrument Sales Value Proportion by Clinical Application in 2025
Table 68. Ad-Tech Medical Instrument Sales Value Proportion by Geographic Area in 2025
Table 69. Ad-Tech Medical Instrument Medical Neural Interface Devices SWOT Analysis
Table 70. Ad-Tech Medical Instrument Recent Developments
Table 71. Sinovation Medical Corporation Information
Table 72. Sinovation Medical Description and Major Businesses
Table 73. Sinovation Medical Product Models, Descriptions and Specifications
Table 74. Sinovation Medical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Sinovation Medical Sales Value Proportion by Product in 2025
Table 76. Sinovation Medical Sales Value Proportion by Clinical Application in 2025
Table 77. Sinovation Medical Sales Value Proportion by Geographic Area in 2025
Table 78. Sinovation Medical Medical Neural Interface Devices SWOT Analysis
Table 79. Sinovation Medical Recent Developments
Table 80. PMT Corporation Corporation Information
Table 81. PMT Corporation Description and Major Businesses
Table 82. PMT Corporation Product Models, Descriptions and Specifications
Table 83. PMT Corporation Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 84. PMT Corporation Sales Value Proportion by Product in 2025
Table 85. PMT Corporation Sales Value Proportion by Clinical Application in 2025
Table 86. PMT Corporation Sales Value Proportion by Geographic Area in 2025
Table 87. PMT Corporation Medical Neural Interface Devices SWOT Analysis
Table 88. PMT Corporation Recent Developments
Table 89. Rishena Medical Corporation Information
Table 90. Rishena Medical Description and Major Businesses
Table 91. Rishena Medical Product Models, Descriptions and Specifications
Table 92. Rishena Medical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 93. Rishena Medical Sales Value Proportion by Product in 2025
Table 94. Rishena Medical Sales Value Proportion by Clinical Application in 2025
Table 95. Rishena Medical Sales Value Proportion by Geographic Area in 2025
Table 96. Rishena Medical Medical Neural Interface Devices SWOT Analysis
Table 97. Rishena Medical Recent Developments
Table 98. CorTec Corporation Information
Table 99. CorTec Description and Major Businesses
Table 100. CorTec Product Models, Descriptions and Specifications
Table 101. CorTec Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 102. CorTec Recent Developments
Table 103. Spes Medica Corporation Information
Table 104. Spes Medica Description and Major Businesses
Table 105. Spes Medica Product Models, Descriptions and Specifications
Table 106. Spes Medica Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 107. Spes Medica Recent Developments
Table 108. Blackrock Neurotech Corporation Information
Table 109. Blackrock Neurotech Description and Major Businesses
Table 110. Blackrock Neurotech Product Models, Descriptions and Specifications
Table 111. Blackrock Neurotech Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 112. Blackrock Neurotech Recent Developments
Table 113. Alpha Omega Corporation Information
Table 114. Alpha Omega Description and Major Businesses
Table 115. Alpha Omega Product Models, Descriptions and Specifications
Table 116. Alpha Omega Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 117. Alpha Omega Recent Developments
Table 118. Sensomedical Corporation Information
Table 119. Sensomedical Description and Major Businesses
Table 120. Sensomedical Product Models, Descriptions and Specifications
Table 121. Sensomedical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 122. Sensomedical Recent Developments
Table 123. Unique Medical Corporation Information
Table 124. Unique Medical Description and Major Businesses
Table 125. Unique Medical Product Models, Descriptions and Specifications
Table 126. Unique Medical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 127. Unique Medical Recent Developments
Table 128. inomed Corporation Information
Table 129. inomed Description and Major Businesses
Table 130. inomed Product Models, Descriptions and Specifications
Table 131. inomed Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 132. inomed Recent Developments
Table 133. ALCIS Corporation Information
Table 134. ALCIS Description and Major Businesses
Table 135. ALCIS Product Models, Descriptions and Specifications
Table 136. ALCIS Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 137. ALCIS Recent Developments
Table 138. FHC Corporation Information
Table 139. FHC Description and Major Businesses
Table 140. FHC Product Models, Descriptions and Specifications
Table 141. FHC Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 142. FHC Recent Developments
Table 143. LivaNova Corporation Information
Table 144. LivaNova Description and Major Businesses
Table 145. LivaNova Product Models, Descriptions and Specifications
Table 146. LivaNova Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 147. LivaNova Recent Developments
Table 148. Precision Neuroscience Corporation Information
Table 149. Precision Neuroscience Description and Major Businesses
Table 150. Precision Neuroscience Product Models, Descriptions and Specifications
Table 151. Precision Neuroscience Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 152. Precision Neuroscience Recent Developments
Table 153. NeuroPace Corporation Information
Table 154. NeuroPace Description and Major Businesses
Table 155. NeuroPace Product Models, Descriptions and Specifications
Table 156. NeuroPace Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 157. NeuroPace Recent Developments
Table 158. WISE Corporation Information
Table 159. WISE Description and Major Businesses
Table 160. WISE Product Models, Descriptions and Specifications
Table 161. WISE Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 162. WISE Recent Developments
Table 163. SceneRay Medical Corporation Information
Table 164. SceneRay Medical Description and Major Businesses
Table 165. SceneRay Medical Product Models, Descriptions and Specifications
Table 166. SceneRay Medical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 167. SceneRay Medical Recent Developments
Table 168. PINS Medical Corporation Information
Table 169. PINS Medical Description and Major Businesses
Table 170. PINS Medical Product Models, Descriptions and Specifications
Table 171. PINS Medical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 172. PINS Medical Recent Developments
Table 173. BroRay Technology Corporation Information
Table 174. BroRay Technology Description and Major Businesses
Table 175. BroRay Technology Product Models, Descriptions and Specifications
Table 176. BroRay Technology Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 177. BroRay Technology Recent Developments
Table 178. Medtronic Corporation Information
Table 179. Medtronic Description and Major Businesses
Table 180. Medtronic Product Models, Descriptions and Specifications
Table 181. Medtronic Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 182. Medtronic Recent Developments
Table 183. Abbott Corporation Information
Table 184. Abbott Description and Major Businesses
Table 185. Abbott Product Models, Descriptions and Specifications
Table 186. Abbott Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 187. Abbott Recent Developments
Table 188. Boston Scientific Corporation Information
Table 189. Boston Scientific Description and Major Businesses
Table 190. Boston Scientific Product Models, Descriptions and Specifications
Table 191. Boston Scientific Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 192. Boston Scientific Recent Developments
Table 193. Cirtec Medical Corporation Information
Table 194. Cirtec Medical Description and Major Businesses
Table 195. Cirtec Medical Product Models, Descriptions and Specifications
Table 196. Cirtec Medical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 197. Cirtec Medical Recent Developments
Table 198. Integer Corporation Information
Table 199. Integer Description and Major Businesses
Table 200. Integer Product Models, Descriptions and Specifications
Table 201. Integer Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 202. Integer Recent Developments
Table 203. Valtronic Corporation Information
Table 204. Valtronic Description and Major Businesses
Table 205. Valtronic Product Models, Descriptions and Specifications
Table 206. Valtronic Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 207. Valtronic Recent Developments
Table 208. LIFESCAPES Corporation Information
Table 209. LIFESCAPES Description and Major Businesses
Table 210. LIFESCAPES Product Models, Descriptions and Specifications
Table 211. LIFESCAPES Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 212. LIFESCAPES Recent Developments
Table 213. g.tec medical engineering Corporation Information
Table 214. g.tec medical engineering Description and Major Businesses
Table 215. g.tec medical engineering Product Models, Descriptions and Specifications
Table 216. g.tec medical engineering Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 217. g.tec medical engineering Recent Developments
Table 218. Neurostyle Corporation Information
Table 219. Neurostyle Description and Major Businesses
Table 220. Neurostyle Product Models, Descriptions and Specifications
Table 221. Neurostyle Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 222. Neurostyle Recent Developments
Table 223. ZhenTec Corporation Information
Table 224. ZhenTec Description and Major Businesses
Table 225. ZhenTec Product Models, Descriptions and Specifications
Table 226. ZhenTec Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 227. ZhenTec Recent Developments
Table 228. RxHeal Medical Corporation Information
Table 229. RxHeal Medical Description and Major Businesses
Table 230. RxHeal Medical Product Models, Descriptions and Specifications
Table 231. RxHeal Medical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 232. RxHeal Medical Recent Developments
Table 233. Xiangyu Medical Corporation Information
Table 234. Xiangyu Medical Description and Major Businesses
Table 235. Xiangyu Medical Product Models, Descriptions and Specifications
Table 236. Xiangyu Medical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 237. Xiangyu Medical Recent Developments
Table 238. Neurobots Corporation Information
Table 239. Neurobots Description and Major Businesses
Table 240. Neurobots Product Models, Descriptions and Specifications
Table 241. Neurobots Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 242. Neurobots Recent Developments
Table 243. LANG Corporation Information
Table 244. LANG Description and Major Businesses
Table 245. LANG Product Models, Descriptions and Specifications
Table 246. LANG Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 247. LANG Recent Developments
Table 248. MEF Corporation Information
Table 249. MEF Description and Major Businesses
Table 250. MEF Product Models, Descriptions and Specifications
Table 251. MEF Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 252. MEF Recent Developments
Table 253. StairMed Corporation Information
Table 254. StairMed Description and Major Businesses
Table 255. StairMed Product Models, Descriptions and Specifications
Table 256. StairMed Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 257. StairMed Recent Developments
Table 258. Neuralink Corporation Information
Table 259. Neuralink Description and Major Businesses
Table 260. Neuralink Product Models, Descriptions and Specifications
Table 261. Neuralink Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 262. Neuralink Recent Developments
Table 263. Paradromics Corporation Information
Table 264. Paradromics Description and Major Businesses
Table 265. Paradromics Product Models, Descriptions and Specifications
Table 266. Paradromics Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 267. Paradromics Recent Developments
Table 268. Synchron Corporation Information
Table 269. Synchron Description and Major Businesses
Table 270. Synchron Product Models, Descriptions and Specifications
Table 271. Synchron Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 272. Synchron Recent Developments
Table 273. Key Raw Materials Distribution
Table 274. Raw Materials Key Suppliers
Table 275. Critical Raw Material Supplier Concentration (2025) & Risk Index
Table 276. Milestones in Production Technology Evolution
Table 277. Distributors List
Table 278. Market Trends and Market Evolution
Table 279. Market Drivers and Opportunities
Table 280. Market Challenges, Risks, and Restraints
Table 281. Research Programs/Design for This Report
Table 282. Key Data Information from Secondary Sources
Table 283. Key Data Information from Primary Sources

List of Figures
Figure 1. Medical Neural Interface Devices Product Picture
Figure 2. Global Medical Neural Interface Devices Market Size Growth Rate by Product Architecture, 2021 vs 2025 vs 2032 (US$ Million)
Figure 3. Standalone Neural Interface Electrodes and Arrays Product Picture
Figure 4. Integrated Implantable Neural Interface Systems Product Picture
Figure 5. Non-invasive Medical Brain-Computer Interface Systems Product Picture
Figure 6. Global Medical Neural Interface Devices Market Size Growth Rate by Interface Placement and Neural Target, 2021 vs 2025 vs 2032 (US$ Million)
Figure 7. Cortical Surface Interfaces Product Picture
Figure 8. Intracortical Interfaces Product Picture
Figure 9. Deep Intracerebral Interfaces Product Picture
Figure 10. Spinal Cord Interfaces Product Picture
Figure 11. Peripheral Nerve Interfaces Product Picture
Figure 12. Endovascular Neural Interfaces Product Picture
Figure 13. Non-invasive CNS Interfaces Product Picture
Figure 14. Global Medical Neural Interface Devices Market Size Growth Rate by Clinical Application, 2021 vs 2025 vs 2032 (US$ Million)
Figure 15. Epilepsy Diagnosis, Localization and Presurgical Mapping
Figure 16. Intraoperative Neural Mapping and Neuromonitoring
Figure 17. Functional Neurosurgery and Therapeutic Neuromodulation Support
Figure 18. Neurorehabilitation and Motor Recovery
Figure 19. Assistive Communication and Digital Device Control
Figure 20. Motor and Sensory Neuroprosthetic Restoration
Figure 21. Medical Neural Interface Devices Report Years Considered
Figure 22. Global Medical Neural Interface Devices Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 23. Global Medical Neural Interface Devices Revenue (US$ Million), 2021-2032
Figure 24. Global Medical Neural Interface Devices Revenue (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Figure 25. Global Medical Neural Interface Devices Revenue-Based Market Share by Region (2021-2032)
Figure 26. Global Medical Neural Interface Devices Sales (Units), 2021-2032
Figure 27. Global Medical Neural Interface Devices Sales (CAGR) by Region: 2021 vs 2025 vs 2032 (Units)
Figure 28. Global Medical Neural Interface Devices Sales Market Share by Region (2021-2032)
Figure 29. Top 5 and Top 10 Manufacturers Medical Neural Interface Devices Sales Volume Market Share in 2025
Figure 30. Global Medical Neural Interface Devices Revenue-Based Market Share Ranking (2025)
Figure 31. Tier Distribution by Revenue Contribution (2021 vs 2025)
Figure 32. Standalone Neural Interface Electrodes and Arrays Revenue-Based Market Share by Manufacturer in 2025
Figure 33. Integrated Implantable Neural Interface Systems Revenue-Based Market Share by Manufacturer in 2025
Figure 34. Non-invasive Medical Brain-Computer Interface Systems Revenue-Based Market Share by Manufacturer in 2025
Figure 35. Global Medical Neural Interface Devices Sales Volume-Based Market Share by Product Architecture (2021-2032)
Figure 36. Global Medical Neural Interface Devices Revenue-Based Market Share by Product Architecture (2021-2032)
Figure 37. Global Medical Neural Interface Devices ASP by Product Architecture (US$/Unit), 2021-2032
Figure 38. Global Medical Neural Interface Devices Sales Volume-Based Market Share by Interface Placement and Neural Target (2021-2032)
Figure 39. Global Medical Neural Interface Devices Revenue-Based Market Share by Interface Placement and Neural Target (2021-2032)
Figure 40. Global Medical Neural Interface Devices ASP by Interface Placement and Neural Target (US$/Unit), 2021-2032
Figure 41. Global Medical Neural Interface Devices Revenue-Based Market Share (2021-2032)
Figure 42. Global Medical Neural Interface Devices Sales Market Share by Clinical Application (2021-2032)
Figure 43. Global Medical Neural Interface Devices Revenue-Based Market Share by Clinical Application (2021-2032)
Figure 44. Global Medical Neural Interface Devices ASP by Clinical Application (US$/Unit), 2021-2032
Figure 45. North America Medical Neural Interface Devices Sales YoY (Units), 2021-2032
Figure 46. North America Medical Neural Interface Devices Revenue YoY (US$ Million), 2021-2032
Figure 47. North America Top 5 Manufacturers Medical Neural Interface Devices Sales Revenue (US$ Million) in 2025
Figure 48. North America Medical Neural Interface Devices Sales Volume (Units) by Clinical Application (2021-2032)
Figure 49. North America Medical Neural Interface Devices Sales Revenue (US$ Million) by Clinical Application (2021-2032)
Figure 50. US Medical Neural Interface Devices Revenue (US$ Million), 2021-2032
Figure 51. Canada Medical Neural Interface Devices Revenue (US$ Million), 2021-2032
Figure 52. Mexico Medical Neural Interface Devices Revenue (US$ Million), 2021-2032
Figure 53. Europe Medical Neural Interface Devices Sales YoY (Units), 2021-2032
Figure 54. Europe Medical Neural Interface Devices Revenue YoY (US$ Million), 2021-2032
Figure 55. Europe Top 5 Manufacturers Medical Neural Interface Devices Sales Revenue (US$ Million) in 2025
Figure 56. Europe Medical Neural Interface Devices Sales Volume (Units) by Clinical Application (2021-2032)
Figure 57. Europe Medical Neural Interface Devices Sales Revenue (US$ Million) by Clinical Application (2021-2032)
Figure 58. Germany Medical Neural Interface Devices Revenue (US$ Million), 2021-2032
Figure 59. France Medical Neural Interface Devices Revenue (US$ Million), 2021-2032
Figure 60. U.K. Medical Neural Interface Devices Revenue (US$ Million), 2021-2032
Figure 61. Italy Medical Neural Interface Devices Revenue (US$ Million), 2021-2032
Figure 62. Russia Medical Neural Interface Devices Revenue (US$ Million), 2021-2032
Figure 63. Asia-Pacific Medical Neural Interface Devices Sales YoY (Units), 2021-2032
Figure 64. Asia-Pacific Medical Neural Interface Devices Revenue YoY (US$ Million), 2021-2032
Figure 65. Asia-Pacific Top 8 Manufacturers Medical Neural Interface Devices Sales Revenue (US$ Million) in 2025
Figure 66. Asia-Pacific Medical Neural Interface Devices Sales Volume (Units) by Clinical Application (2021-2032)
Figure 67. Asia-Pacific Medical Neural Interface Devices Sales Revenue (US$ Million) by Clinical Application (2021-2032)
Figure 68. Indonesia Medical Neural Interface Devices Revenue (US$ Million), 2021-2032
Figure 69. Japan Medical Neural Interface Devices Revenue (US$ Million), 2021-2032
Figure 70. South Korea Medical Neural Interface Devices Revenue (US$ Million), 2021-2032
Figure 71. China Taiwan Medical Neural Interface Devices Revenue (US$ Million), 2021-2032
Figure 72. India Medical Neural Interface Devices Revenue (US$ Million), 2021-2032
Figure 73. Central and South America Medical Neural Interface Devices Sales YoY (Units), 2021-2032
Figure 74. Central and South America Medical Neural Interface Devices Revenue YoY (US$ Million), 2021-2032
Figure 75. Central and South America Top 5 Manufacturers Medical Neural Interface Devices Sales Revenue (US$ Million) in 2025
Figure 76. Central and South America Medical Neural Interface Devices Sales Volume (Units) by Clinical Application (2021-2032)
Figure 77. Central and South America Medical Neural Interface Devices Sales Revenue (US$ Million) by Clinical Application (2021-2032)
Figure 78. Brazil Medical Neural Interface Devices Revenue (US$ Million), 2021-2032
Figure 79. Argentina Medical Neural Interface Devices Revenue (US$ Million), 2021-2032
Figure 80. Middle East, and Africa Medical Neural Interface Devices Sales YoY (Units), 2021-2032
Figure 81. Middle East and Africa Medical Neural Interface Devices Revenue YoY (US$ Million), 2021-2032
Figure 82. Middle East and Africa Top 5 Manufacturers Medical Neural Interface Devices Sales Revenue (US$ Million) in 2025
Figure 83. Middle East and Africa Medical Neural Interface Devices Sales Volume (Units) by Clinical Application (2021-2032)
Figure 84. Middle East and Africa Medical Neural Interface Devices Sales Revenue (US$ Million) by Clinical Application (2021-2032)
Figure 85. GCC Countries Medical Neural Interface Devices Revenue (US$ Million), 2021-2032
Figure 86. Turkey Medical Neural Interface Devices Revenue (US$ Million), 2021-2032
Figure 87. Egypt Medical Neural Interface Devices Revenue (US$ Million), 2021-2032
Figure 88. South Africa Medical Neural Interface Devices Revenue (US$ Million), 2021-2032
Figure 89. Medical Neural Interface Devices Industry Chain Mapping
Figure 90. Regional Medical Neural Interface Devices Manufacturing Base Distribution (%)
Figure 91. Global Medical Neural Interface Devices Production Market Share by Region (2021-2032)
Figure 92. Medical Neural Interface Devices Production Process
Figure 93. Regional Medical Neural Interface Devices Production Cost Structure
Figure 94. Channels of Distribution (Direct Vs Distribution)
Figure 95. Bottom-up and Top-down Approaches for This Report
Figure 96. Data Triangulation
Figure 97. Key Executives Interviewed